Astria Therapeutics
ATXS
ATXS
33 hedge funds and large institutions have $81.4M invested in Astria Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.25M | |
| 2 | +$307K | |
| 3 | +$238K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$140K |
| 5 |
DM
Deerfield Management
New York
|
+$119K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$325K | |
| 3 | -$302K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$176K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$103K |